Manufacturer record
Hindustan Laboratories Limited: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
21 batches manufactured by Hindustan Laboratories Limited (Maharashtra) were declared Not of Standard Quality between December 2019 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
21 records linked to Hindustan Laboratories Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Povidone-Iodine Ointment USP 5% w/w | EP25081ALMfg 2025-10 · Exp 2027-09 | The sample does not conform to claim as per USP 2025 in respect to the Assay of Povidone-Iodine as Available IodineAssay | RDTL, ChandigarhCDSCO lab | Jun 2026 |
| Dicyclomine Tablets IP 10 mg | THY25005ALMfg 2025-04 · Exp 2028-03 | Sample does not conform to IP standards with respect to Description.Description | RDTL ErnakulamState lab | Jun 2026 |
| Telmisartan Tablets IP 40 mg | TEP25086ALMfg 2025-04 · Exp 2027-03 | DescriptionDescription | RDTL, Bellary, KarnatakaState lab | May 2026 |
| Dicyclomine Tablets IP | THY25001ALMfg 2025-01 · Exp 2027-12 | DescriptionDescription | RDTL, ErnakulamState lab | Mar 2026 |
| Glipizide Tablets IP 5 mg | TCY24030ALMfg 2024-12 · Exp 2026-11 | DescriptionDescription | DTL, Madurai-19State lab | Feb 2026 |
| Iron and folic acid syrup IP | LAV25159ALMfg 2025-08 · Exp 2026-10 | DescriptionDescription | Drugs Testing Laboratory, Madurai-19State lab | Jan 2026 |
| Telmisartan Tablets IP 40MG | TEP25123ALMfg 2025-05 · Exp 2027-04 | The sample does not confirm to IP 2022 requirement with respect to Dissolution TestDissolution | DTL,Dalgate Srinagar Kashmir (J & K)State lab | Dec 2025 |
| Paracetamol Tablets IP 650mg | TEM24011ALMfg 2024-10 · Exp 2026-09 | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab | Nov 2025 |
| FOLIC ACID TABLETS IP 5mg (FOLIC ACID TABLETS IP 5mg) | TFN25012ALMfg 2025-07 · Exp 2027-06 | Uniformity of contentUniformity of weight/content | SDTL, PunjabState lab | Oct 2025 |
| Telmisartan Tablets I.P. (20 mg) | TFI24009ALMfg 2024-08 · Exp 2026-07 | DescriptionDescription | MDTL Kathua ( J&K)State lab | Sep 2025 |
| Paracetamol Tablets IP 650 mg | TEM25002ALMfg 2025-03 · Exp 2025-02 | DissolutionDissolution | DTL/BaddiState lab | Sep 2025 |
| Telmisartan Tablets I.P. (20 mg) | TFI24009ALMfg 2024-08 · Exp 2026-07 | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua, Jammu and KashmirState lab | Jul 2025 |
| Dicyclomine Tablets IP | THY24010ALMfg 2024-08 · Exp 2026-07 | Description.Description | DTL MaduraiState lab | Jun 2025 |
| Diclofenac Sodium Tablets IP | THB24028ALMfg 2024-07 · Exp 2026-06 | Sample does not conform to IP specification for Enteric Coated Tablets with respect to DisintegrationDisintegration | DTL ChennaiState lab | Apr 2025 |
| Aspirin Tablets | TAS2301 0ALMfg 2023-10 · Exp 2025-09 | Sample does not conform to IP Specification for Aspirin Tablets with respect to the content of Aspirin.Other | DTL MaduraiState lab | Jan 2025 |
| Diphenhydramine HCl, Ammonium- Chloride and Sodium Citrate Cough Expectorant | LDS2005ALMfg 2022-12 · Exp 2024-05 | Assay of MentholAssay | RDTL ChandigarhCDSCO lab | Mar 2023 |
| Pantoprazole Gastro- Resistant Tablets IP 40 mg | TDJ2010ALMfg 2022-03 · Exp 2023-08 | DissolutionDissolution | CDL KolkataCDSCO lab | Nov 2022 |
| ZINC SULPHATE DISPERSIBLE TABLETS IP 20 mg | TAC0006ALMfg 2020-06 · Exp 2022-05 | Disintegration TestDisintegration | RDTL GuwahatiCDSCO lab | Apr 2021 |
| Calcium with Vitamin D3 Tablets | TAK8048ALMfg 2018-04 · Exp 2020-03 | Assay of Vitamin D3Assay | RDTL GuwahatiState lab | Dec 2019 |
| Calcium with Vitamin D3 Tablets | TAK8162ALMfg 2018-06 · Exp 2020-05 | Assay of Vitamin D3Assay | RDTL GuwahatiState lab | Dec 2019 |
| Calcium with Vitamin D3 Tablets | TAK8137ALMfg 2018-06 · Exp 2020-05 | Assay of Vitamin D3Assay | RDTL GuwahatiState lab | Dec 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.